NJ It Pays to Plug In Grant

The Illinois Department of Commerce and Economic Opportunity is issuing this Notice of Funding Opportunity (“NOFO”) to implement a capital grant program to support reproductive health care facilities in Illinois that are experiencing increased demand for their services. Following the Supreme Court decision to overturn Roe v Wade in 2022, Illinois clinics have seen an influx of out-of-state patients, resulting in limited capacity and stress to reproductive health care service providers. To address the need to maintain and expand access to care, the Illinois Reproductive Health Facilities Capital Grant Program will help abortion providers in Illinois address their needs for capital investment. Grant funds may be used to invest in facility construction or durable equipment.

The City of Framingham is accepting applications for its Microenterprise Assistance Program. The Microenterprise Assistance Program will provide ten one-time grants of $7,200 to eligible businesses. All start-up businesses and existing businesses must be physically located in Framingham and will be required to submit a business plan when applying for a Microenterprise grant. Funds can be used for payroll expenses, leases, business mortgages, or purchasing new equipment to expand business offerings.

The Restaurant Business Development Program is designed to support restaurant owners like you by offering comprehensive business development assistance valued at $15,000. This program ensures your business is financially sustainable, operationally sound, and advancing towards your next culinary endeavor. Cohorts will receive six months of intentional consultations followed up with educational training service, continuous training and services, extend to support you with procedures that will help you process and maintain your business.

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. All applications submitted under this NOFO must be supported by sufficient preliminary data demonstrating bioavailability (if applicable) and documentation that the natural product produces a reproducible and measurable impact on target engagement (i.e., measure of the mechanism of action). Only in cases when it is not possible/practical to measure target engagement in the patient population of interest or when there is a fundamental understanding of the products mechanism of action will this preliminary data requirement be waived. Applications submitted to this NOFO should propose a mid-phase clinical trial to do the following: determine the optimal dose or formulation of a given natural product for use in a future multi-site efficacy trial; or determine which patient phenotypes will be responders versus non-responders to the natural product to inform inclusion/exclusion criteria of a future efficacy trial. Clinical trials submitted under this NOFO are expected to be hypothesis based, milestone-driven, and directly related to the research priorities and mission of NCCIH. This NOFO will not support single-site or multi-site efficacy or effectiveness trials, nor will it support trials to test natural products for the treatment or prevention of cancer. Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NO

The Black Ambition Prize competition provides a platform for underrepresented founders across the nation to access growth capital, coaching, and a curated community of innovators and mentors. Eligible applicants consist of diverse innovators building early-stage ventures